Literature DB >> 26965017

Treatment trials for diabetic macular oedema.

D McLeod1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26965017      PMCID： PMC4941059          DOI： 10.1038/eye.2016.40

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.

Authors:  Ji Won Lim; Hyo Kyoung Lee; Min Cheol Shin
Journal:  Ophthalmologica       Date:  2011-10-12       Impact factor: 3.250

Review 2.  A review of therapies for diabetic macular oedema and rationale for combination therapy.

Authors:  W M K Amoaku; S Saker; E A Stewart
Journal:  Eye (Lond)       Date:  2015-06-26       Impact factor: 3.775

3.  Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.

Authors:  Hamid Ahmadieh; Alireza Ramezani; Nasser Shoeibi; Bijan Bijanzadeh; Ali Tabatabaei; Mohsen Azarmina; Masoud Soheilian; Gholamreza Keshavarzi; Mohammad-Reza Mohebbi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-05       Impact factor: 3.117

4.  Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.

Authors:  Masoud Soheilian; Alireza Ramezani; Arash Obudi; Bijan Bijanzadeh; Masoud Salehipour; Mehdi Yaseri; Hamid Ahmadieh; Mohammad H Dehghan; Mohsen Azarmina; Siamak Moradian; Gholam A Peyman
Journal:  Ophthalmology       Date:  2009-04-19       Impact factor: 12.079

5.  Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema.

Authors:  Hatem M Marey; Amin F Ellakwa
Journal:  Clin Ophthalmol       Date:  2011-07-22

6.  Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.

Authors:  Ron Adelman; Aaron Parnes; Zofia Michalewska; Barbara Parolini; Claude Boscher; Didier Ducournau
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.